Gensight market cap
WebGenSight’s Profile, Revenue and Employees. GenSight is a provider of project portfolio management software for the organizations. GenSight’s primary competitors include … WebDec 31, 2024 · GenSight Biologics S.A. specializes in the research and development of gene therapies for the treatment of mitochondrial diseases and eye neurodegeneratives.
Gensight market cap
Did you know?
WebView the latest GenSight Biologics S.A. (SIGHT) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebFind real-time GSGTF - Gensight Biologics SA stock quotes, company profile, news and forecasts from CNN Business.
WebGenSight Biologics SA is a clinical-stage gene therapy company. It is engaged in research and development of novel therapies for mitochondrial and neurodegenerative. The firm also provides ophthalmology services which develops products to restore eyesight to patients suffering from retinal diseases. WebThis information is intended for investors and the financial community. In this section, we provide investors and the media with pertinent regulatory and financial information as well as news and announcements about the company’s activities
WebMarket Cap: 112.174M: Beta (5Y Monthly) 2.21: PE Ratio (TTM) N/A: EPS (TTM)-0.6500: Earnings Date: Mar 24, 2024: Forward Dividend & Yield: N/A (N/A) Ex-Dividend Date: N/A: 1y Target Est: 9.40 Find out all the key statistics for GenSight Biologics S.A. (SIGHT.PA), including … Stocks sink after Fed minutes despite cooler inflation: Stock market news … PARIS, March 10, 2024--Regulatory News: GenSight Biologics (Euronext: SIGHT, … Find the latest GenSight Biologics S.A. (SIGHT.PA) stock discussion in Yahoo … WebStock analysis for GenSight Biologics SA (SIGHT:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebThe average market cap of companies in the sector is 192.3 M with a standard deviation of 297.2 M. GenSight Biologics S.A.'s Market Cap of 178.9 M ranks in the 70.9% percentile …
WebMar 29, 2024 · Market Cap €97.6M; Shares Outstanding 46.34M; Public Float 31.92M; Beta N/A; Rev. per Employee €68.42K; P/E Ratio N/A; EPS N/A; Yield N/A; Dividend N/A; Ex … bark river mini canadianWebGensight Biologics Market Capitalization is currently at 165.35 M. Market Capitalization is the total market value of Gensight Biologics' equity. It is one of many ways to value … suzuki grand vitara iiWebSearch stock, chart, recent trades, company information, trading information, company news, fundamentals suzuki grand vitara hybrid cenaWebGet the latest Gensight Biologics SA (SIGHT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … bark river gunny scandi 3vWebApr 7, 2024 · SIGHT’s market cap is 106.17 Mil. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often … bark river mini canadian knifeWebMarket Cap $177.41 M Shares Outstanding 46.34 M Public Float 31.92 M Yield GSGTF is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short … bark river mini kalahari sportsmanWebScale renewals management without increasing cost. “Using Gainsight for renewal management has allowed us to both specialize and scale our Customer Success teams. … bark river mikro canadian